These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34630708)

  • 1. Long non-coding RNA XIST accelerates hepatic carcinoma progression by targeting the microRNA-320a/PIK3CA axis.
    Yang L; Xie F; Xu W; Xu T; Ni Y; Tao X; Zang Y; Jin J
    Oncol Lett; 2021 Nov; 22(5):801. PubMed ID: 34630708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA XIST/miR‑129‑2‑3p axis targets CCP110 to regulate the proliferation, invasion and migration of endometrial cancer cells.
    Chen S; Liang Y; Shen Y; Wang X
    Exp Ther Med; 2023 Apr; 25(4):159. PubMed ID: 36911384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis.
    Wang X; Su Y; Yin C
    Bioengineered; 2021 Dec; 12(2):11622-11633. PubMed ID: 34720057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA XIST regulates cell proliferation, migration and invasion via regulating miR-30b and RECK in nasopharyngeal carcinoma.
    Sun L; Zhang M; Qu H
    Oncol Lett; 2021 Apr; 21(4):256. PubMed ID: 33664820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of XIST facilitates cell proliferation, invasion and suppresses cell apoptosis by reducing radio-sensitivity of glioma cells via miR-329-3p/CREB1 axis.
    Wang YP; Li HQ; Chen JX; Kong FG; Mo ZH; Wang JZ; Huang KM; Li XN; Yan Y
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3190-3203. PubMed ID: 32271437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA XIST promotes the progression of breast cancer by sponging miR-125b-5p to modulate NLRC5.
    Zong Y; Zhang Y; Hou D; Xu J; Cui F; Qin Y; Sun X
    Am J Transl Res; 2020; 12(7):3501-3511. PubMed ID: 32774715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA XIST enhanced TGF-β2 expression by targeting miR-141-3p to promote pancreatic cancer cells invasion.
    Sun J; Zhang Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 11. The expression of lncRNA XIST in hepatocellular carcinoma cells and its effect on biological function.
    Dong Z; Yang J; Zheng F; Zhang Y
    J BUON; 2020; 25(5):2430-2437. PubMed ID: 33277866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lncRNA XIST promotes proliferation, migration and invasion of gastric cancer cells by targeting miR-337.
    Zheng W; Li J; Zhou X; Cui L; Wang Y
    Arab J Gastroenterol; 2020 Sep; 21(3):199-206. PubMed ID: 32830093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA XIST Protects Against Polycystic Ovary Syndrome via the Regulation of miR-212-3p/RASA1 Axis.
    Xu X; Yin C; Dong B; Li Y; Liu S; Chen J
    Biochem Genet; 2024 Apr; ():. PubMed ID: 38609670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory role of microRNA-320a in the proliferation, migration, invasion, and apoptosis of trophoblasts and endothelial cells by targeting estrogen-related receptor γ.
    Liu RH; Meng Q; Shi YP; Xu HS
    J Cell Physiol; 2018 Jan; 234(1):682-691. PubMed ID: 30216440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2.
    Liu A; Liu L; Lu H
    J Cell Physiol; 2019 Aug; 234(8):13747-13761. PubMed ID: 30656681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA XIST promotes glioma proliferation and metastasis through miR-133a/SOX4.
    Luo C; Quan Z; Zhong B; Zhang M; Zhou B; Wang S; Luo X; Tang C
    Exp Ther Med; 2020 Mar; 19(3):1641-1648. PubMed ID: 32104215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LINC01963 inhibits progression of pancreatic carcinoma by targeting miR-641/TMEFF2.
    Li K; Han H; Gu W; Cao C; Zheng P
    Biomed Pharmacother; 2020 Sep; 129():110346. PubMed ID: 32559621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
    Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.
    Jiang R; Zhang H; Zhou J; Wang J; Xu Y; Zhang H; Gu Y; Fu F; Shen Y; Zhang G; Feng L; Zhang X; Chen Y; Shen F
    Cell Death Dis; 2021 Feb; 12(2):145. PubMed ID: 33542185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
    Zhao CH; Bai XF; Hu XH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.